RT @CARTTherapy: Safety and Efficacy of Anti-CD19-CAR T Cell Combined With PD 1 Inhibitor Therapy in a Patient With Refractory PTLD: Case R…
235 followers
1,972 followers
RT @CARTTherapy: Safety and Efficacy of Anti-CD19-CAR T Cell Combined With PD 1 Inhibitor Therapy in a Patient With Refractory PTLD: Case R…
114 followers
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review https://t.co/lzTondhK2u ht
417 followers
RT @CARTTherapy: Safety and Efficacy of Anti-CD19-CAR T Cell Combined With PD 1 Inhibitor Therapy in a Patient With Refractory PTLD: Case R…